Recital 4, Regulation (EU) 2024/324

In forcesince 19 Jan 2024

Commission Implementing Regulation (EU) 2018/670 [Commission Implementing Regulation (EU) 2018/670 of 30 April 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bromuconazole, buprofezin, haloxyfop-P and napropamide (OJ L 113, 3.5.2018, p. 1, ELI: http://data.europa.eu/eli/reg_impl/2018/670/oj).] extended the approval period of the active substance bromuconazole until 31 January 2024.